Fig. 8

Oral hypoglycemic efficacy in Type 2 Diabetic Mice. A Relative BGL changes and B pharmacodynamic data after oral administration with LIRA/CA Complex, Free LIRA solution, and saline at a LIRA oral dose of 2 mg kg^− 1 and subcutaneous injection dose of 0.2 mg kg^− 1; C Relative BGL changes and D pharmacodynamic data after oral administration with LIRA/CA@Zein/RLs, LIRA/CA@Zein and LIRA@Zein/RLs at a LIRA oral dose of 4 mg kg^− 1 and subcutaneous injection dose of 0.4 mg kg^− 1 (n = 6)